company background image
SQURPHARMA logo

Square Pharmaceuticals DSE:SQURPHARMA Stock Report

Last Price

৳197.70

Market Cap

৳175.3b

7D

-3.5%

1Y

-5.8%

Updated

12 Jun, 2024

Data

Company Financials +

Square Pharmaceuticals PLC.

DSE:SQURPHARMA Stock Report

Market Cap: ৳175.3b

SQURPHARMA Stock Overview

Square Pharmaceuticals PLC. and its subsidiaries develop, manufacture, and market drugs for health care for various live species in Bangladesh.

SQURPHARMA fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance3/6
Financial Health5/6
Dividends5/6

Square Pharmaceuticals PLC. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Square Pharmaceuticals
Historical stock prices
Current Share Price৳197.70
52 Week High৳222.70
52 Week Low৳197.20
Beta0.17
1 Month Change-6.39%
3 Month Change-8.39%
1 Year Change-5.77%
3 Year Change-7.40%
5 Year Change-14.64%
Change since IPO9,261.73%

Recent News & Updates

Recent updates

Shareholder Returns

SQURPHARMABD PharmaceuticalsBD Market
7D-3.5%-4.0%-4.0%
1Y-5.8%-25.4%-27.3%

Return vs Industry: SQURPHARMA exceeded the BD Pharmaceuticals industry which returned -25.4% over the past year.

Return vs Market: SQURPHARMA exceeded the BD Market which returned -27.3% over the past year.

Price Volatility

Is SQURPHARMA's price volatile compared to industry and market?
SQURPHARMA volatility
SQURPHARMA Average Weekly Movement1.4%
Pharmaceuticals Industry Average Movement6.7%
Market Average Movement5.2%
10% most volatile stocks in BD Market7.7%
10% least volatile stocks in BD Market3.3%

Stable Share Price: SQURPHARMA has not had significant price volatility in the past 3 months.

Volatility Over Time: SQURPHARMA's weekly volatility (1%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195812,503Tapan Chowdhurywww.squarepharma.com.bd

Square Pharmaceuticals PLC. and its subsidiaries develop, manufacture, and market drugs for health care for various live species in Bangladesh. The company offers generic pharmaceuticals, basic chemicals, and animal health products.

Square Pharmaceuticals PLC. Fundamentals Summary

How do Square Pharmaceuticals's earnings and revenue compare to its market cap?
SQURPHARMA fundamental statistics
Market cap৳175.25b
Earnings (TTM)৳20.24b
Revenue (TTM)৳68.81b

8.7x

P/E Ratio

2.5x

P/S Ratio

Is SQURPHARMA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SQURPHARMA income statement (TTM)
Revenue৳68.81b
Cost of Revenue৳35.60b
Gross Profit৳33.21b
Other Expenses৳12.97b
Earnings৳20.24b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)22.83
Gross Margin48.27%
Net Profit Margin29.41%
Debt/Equity Ratio1.3%

How did SQURPHARMA perform over the long term?

See historical performance and comparison

Dividends

5.3%

Current Dividend Yield

46%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.